NGM Biopharmaceuticals, Inc. Cash Flow from Operating Activities 2019-2023 | NGM

NGM Biopharmaceuticals, Inc. cash flow from operating activities from 2019 to 2023. Cash flow from operating activities can be defined as a company's cash flows from operations.
NGM Biopharmaceuticals, Inc. Annual Cash Flow Ops
(Millions of US $)
2023 $-132
2022 $-144
2021 $-73
2020 $-83
2019 $-41
2018 $-8
2017 $-17